Does a specialist unit improve outcomes for hospitalized patients with Parkinson's disease?

Abstract

ObjectiveSuboptimal management of Parkinson's disease (PD) medication in hospital may lead to avoidable complications. We introduced an in-patient PD unit for those admitted urgently with general medical problems. We explored the effect of the unit on medication management, length of stay and patient experience.MethodsWe conducted a single-center prospective feasibility study. The unit's core features were defined following consultation with patients and professionals: specially trained staff, ready availability of PD drugs, guidelines, and care led by a geriatrician with specialty PD training. Mandatory staff training comprised four 1 h sessions: PD symptoms; medications; therapy; communication and swallowing. Most medication was prescribed using an electronic Prescribing and Administration system (iSOFT) which provided accurate data on time of administration. We compared patient outcomes before and after introduction of the unit.ResultsThe general ward care (n = 20) and the Specialist Parkinson's Unit care (n = 24) groups had similar baseline characteristics. On the specialist unit: less Parkinson's medication was omitted (13% vs 20%, p < 0.001); of the medication that was given, more was given on time (64% vs 50%, p < 0.001); median length of stay was shorter (9 days vs 13 days, p = 0.043) and patients' experience of care was better (p = 0.01).DiscussionIf replicated and generalizable to other hospitals, reductions in length of stay would lead to significant cost savings. The apparent improved outcomes with Parkinson's unit care merit further investigation. We hope to test the hypothesis that specialized units are cost-effective and improve patient care using a randomized controlled trial design.

Missing Dosages and Neuroleptic Usage May Prolong Length of Stay in Hospitalized Parkinson's Disease Patients

“…A recent pilot study prospectively explored the effect of utilizing a specialized Parkinson’s disease care unit (SPDU). This study revealed that fewer medications were omitted, more medications were administered on time, and that patients had a shorter length of stay and a better overall experience [ 26 ]. The authors suggested the need for a larger randomized controlled study to confirm these findings, though admittedly this model would not likely be feasible on a larger scale.…”

A Comparison of Effectiveness of Dohsa‐hou and the Alexander Technique on Happiness, Social Adjustment, Hope, Mental Health, and Quality of Life in Patients with Parkinson's Disease

“…Parkinson's disease is a slowly progressive degenerative neurotic disease that develops when brain cells that are responsible for the production of dopamine die (Skelly et al, ). This disease is one of the most important chronic diseases in elderly people.…”

Measuring Medication Adherence in Parkinson's Disease: A Systematic Review of Contributing Components in Rating Scales

“…21 In PD and other movement disorders, there is a tradition of combining measures from different scales in a "unified" format (eg, Unified Parkinson's Disease Rating Scale, Unified Dyskinesia Rating Scale). 44,45 An effort to reconfigure and combine all measures into a unified PD treatment adherence scale is feasible, as the clinimetric and statistic expertise is available in the PD scientific community, 9,46 and many existing measures could be used to create this unified approach. The resultant measurement tool would need to accommodate the perspectives from all stakeholders, including patients, caregivers, health providers, and other potential informants.…”